Company Filing History:
Years Active: 2012
Title: Innovations in Virus Diagnostics by Peter T G Sillekens
Introduction
Peter T G Sillekens is an accomplished inventor based in Gemonde, Netherlands. He has made significant contributions to the field of virus diagnostics, particularly in the detection of the SARS coronavirus. His work has implications for public health and safety, especially during viral outbreaks.
Latest Patents
Peter T G Sillekens holds a patent for "Nucleic acid sequences that can be used as primers and probes in the amplification and detection of SARS coronavirus." This invention is crucial for diagnosing infections caused by the novel human coronavirus responsible for Severe Acute Respiratory Syndrome (SARS). The patent provides nucleotide sequences that can be utilized in methods for the amplification and detection of SARS nucleic acid. The oligonucleotide sequences are located in the replicase gene, the nucleocapsid gene, and the 3' end non-coding region of the SARS Coronavirus genome. By employing these sequences, a sensitive and specific detection of SARS Coronavirus can be achieved.
Career Highlights
Peter T G Sillekens is associated with Biomerieux, Inc., a company known for its innovations in the field of diagnostics. His work at Biomerieux has allowed him to collaborate with other talented professionals in the industry, enhancing the development of diagnostic tools.
Collaborations
Some of his notable coworkers include Marlieke Joan Overdijk and Saskia Van De Laar. Their collaborative efforts contribute to the advancement of diagnostic technologies and methodologies.
Conclusion
Peter T G Sillekens is a key figure in the field of virus diagnostics, with a focus on the SARS coronavirus. His innovative patent and work at Biomerieux, Inc. highlight his commitment to improving public health through advanced diagnostic solutions.